FY2024 EPS Estimates for Amedisys, Inc. Increased by William Blair (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED - Free Report) - Stock analysts at William Blair increased their FY2024 earnings estimates for shares of Amedisys in a research note issued on Thursday, April 25th. William Blair analyst M. Larew now expects that the health services provider will post earnings of $4.54 per share for the year, up from their prior forecast of $4.37. The consensus estimate for Amedisys' current full-year earnings is $4.58 per share.

Other equities research analysts have also recently issued reports about the company. Cantor Fitzgerald reissued a "neutral" rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday. Royal Bank of Canada increased their price objective on Amedisys from $97.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, March 25th. Raymond James reaffirmed a "market perform" rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, StockNews.com cut Amedisys from a "buy" rating to a "hold" rating in a research report on Friday. Eight investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $97.50.

Amedisys Stock Up 0.1 %

AMED traded up $0.05 during trading on Monday, reaching $91.84. The stock had a trading volume of 235,087 shares, compared to its average volume of 275,729. The stock's 50 day moving average is $92.54 and its two-hundred day moving average is $93.36. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $3.00 billion, a price-to-earnings ratio of -143.65, a P/E/G ratio of 3.41 and a beta of 0.86. Amedisys has a one year low of $73.10 and a one year high of $96.44.

Amedisys (NASDAQ:AMED - Get Free Report) last released its earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, beating analysts' consensus estimates of $1.02 by $0.01. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The business had revenue of $571.41 million for the quarter, compared to analysts' expectations of $565.38 million. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The firm's revenue was up 2.7% on a year-over-year basis.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Exchange Traded Concepts LLC bought a new position in shares of Amedisys in the third quarter worth about $609,000. Commonwealth Equity Services LLC raised its stake in shares of Amedisys by 2.9% in the third quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider's stock worth $364,000 after buying an additional 110 shares during the period. Xponance Inc. raised its stake in shares of Amedisys by 3.2% in the third quarter. Xponance Inc. now owns 4,076 shares of the health services provider's stock worth $381,000 after buying an additional 125 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Amedisys by 12.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,893 shares of the health services provider's stock worth $550,000 after buying an additional 663 shares during the period. Finally, ING Groep NV raised its stake in shares of Amedisys by 257.4% in the third quarter. ING Groep NV now owns 189,800 shares of the health services provider's stock worth $17,727,000 after buying an additional 136,700 shares during the period. Institutional investors own 94.36% of the company's stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.